New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2013
15:04 EDTUPIUroplasty receives compliance letter from Nasdaq
Uroplasty announced today that it has received a letter from Nasdaq notifying the company that it is not in compliance with Listing Rule 5250 (c)(1) because its Annual Report for the year ended December 31, 2012, was not filed on a timely basis with the SEC. As previously announced, the company is currently in the process of reviewing its internal control over financial reporting relating to orders and the payment of sales commissions at the end of fiscal quarters and has been delayed in filing its Form 10-K pending completion of that review. The company expects to complete the review process and file is Form 10-K as soon as practicable. The Company does not currently believe that it is likely that this review will require a material revision of its previously released earnings.
News For UPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
17:01 EDTUPIAmici Capital reports 6.78% passive stake in Uroplasty
Subscribe for More Information
10:02 EDTUPIOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
09:18 EDTUPIUroplasty downgraded to Neutral from Buy at Roth Capital
January 22, 2015
16:05 EDTUPIUroplasty sees FY15 revenue $26.5M-$26.8M, consensus $26.43M
16:03 EDTUPIUroplasty reports Q3 EPS (6c), consensus (4c)
Subscribe for More Information
January 20, 2015
09:23 EDTUPIUroplasty downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum downgraded Uroplasty to Hold based on moderating urgent PC growth and management's focus on acquisitions to drive growth. Price target cut to $2 from $6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use